PACS Group Inc. Securities Fraud Lawsuit: Opportunity for Investors
Investors in PACS Group Inc. (NYSE: PACS) have a chance to take the lead in a securities fraud lawsuit, and here’s what you need to know.
If you bought PACS common stock during the initial public offering (IPO) in April 2024, or between April 11, 2024, and November 5, 2024 (the Class Period), or during the September 2024 secondary public offering (SPO), you could be eligible for compensation until the January 13, 2025, lead plaintiff deadline.
To participate in the class action lawsuit, visit https://rosenlegal.com/submit-form/?case_id=30617 or contact Phillip Kim, Esq. at 866-767-3653, or email case@rosenlegal.com for more information. Remember, if you want to be the lead plaintiff, you must act by January 13, 2025. Leading plaintiffs represent other class members in legal proceedings.
Why opt for Rosen Law Firm? With a focus on securities class actions and shareholder derivative litigation, Rosen Law Firm has a history of substantial successes. The firm has a track record of securing significant settlements and has recovered hundreds of millions of dollars for investors. Choosing experienced counsel is crucial in these matters.
The lawsuit alleges that PACS was involved in submitting false Medicare claims that inflated its income, billing unnecessary therapies to Medicare, and falsifying licensure and staffing documentation. The lawsuit claims that investors suffered losses when the true details came to light.
So, if you’re a PACS investor within the specified periods, this could be an opportunity to seek recourse for any losses you may have incurred.
